inotuzumab,blinatumomab
astellas,amgen,pfizer,ucb pharmaceuticals
['inotuzumab', 'blina ']
congress | #ash22 | poster
giovanni marconi presented a poster about use of inotuzumab ozogamicin in mrd+ pts with #all, without prior hsct. the majority of both ph+ and ph- pts achieved mrd reduction or negativity. median os was not reached.
#medicalcongress #allsm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm